CLINICAL_TRIALS
trial_result
· 2018-09-12
Clinical Trial Update: Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis [Phase 3]
Summary
Phase 3 trial update for M923 in combination with Humira in chronic plaque-type psoriasis; study completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Momenta Pharmaceuticals, Inc. | Conditions: Chronic Plaque Psoriasis, Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-12